Contact Us Careers
English 简体中文 繁體中文
EN 中文 繁體

Oncology Clinical Research

"Anti-cancer Special Force vNKT" is emerging as a rising star in China's immunology community.

Lung Cancer Stomach Cancer Hepatobiliary and Pancreatic Cancers Intestine Cancer Breast Cancer B-cell lymphoma Cervical Cancer Other Solid Tumors
Home > Oncology Clinical Research

Oncology Clinical Research

Malignant lung cancer, with two surgeries and two recurrences, maintaining stable disease condition is fundamental

After undergoing NKT cell therapy, Ms. Liu achieved the expected results. After a long-term follow-up, no new tumors were... ...
View More+

Lung cancer was found during physical examination. Early intervention can reduce the risk of recurrence and metastasis

After undergoing NKT cell therapy, Ms. Chen achieved the expected results. After a long-term follow-up, there was no recu... ...
View More+

The patient with nasopharyngeal cancer has undergone 33 rounds of radiotherapy and 4 rounds of chemotherapy. The latest assessment results are now available

Mr. Zhao achieved the expected results after adopting NKT cell therapy. Over the nearly two years of treatment, multiple ... ...
View More+

How was he treated for advanced colon cancer?

Mr. Yang achieved the expected results after adopting NKT cell therapy. Over a year later, the latest assessment still sh... ...
View More+

In the early stage of poorly differentiated lung adenocarcinoma, surgical treatment is not a permanent solution

During the 32 treatment sessions over 82 months, which underwent continuous changes and adjustments, Mr. Wang's evaluatio... ...
View More+

Targeted therapy combined with cellular immunotherapy after lung cancer surgery further reduces the risk of recurrence

During the 16 months of treatment, which included 9 courses, Mr. Zheng's condition remained stable in multiple follow-up ... ...
View More+

Using case studies, we will guide you to understand the early symptoms of colon cancer

Within half a year, Ms. Huang completed the first phase of treatment. During this follow-up examination, no clear signs o... ...
View More+

How to maintain stability in patients with advanced lung cancer who have relapsed after targeted therapy?

In just over half a year, Ms. Liu completed the first phase of treatment. During this follow-up examination, no clear sig... ...
View More+

After lung cancer surgery, cell therapy is used to eliminate residual cancer cells, achieving long-term stability

Over the course of more than half a year, Mr. Ge completed the first phase of treatment. During this follow-up examinatio... ...
View More+

What should I do if I am still worried about breast cancer after targeted therapy?

Over the course of more than half a year, Ms. Li completed the first phase of treatment. During this follow-up examinatio... ...
View More+
About Lehe
Corporate Culture Founder's Introduction Lehe News Story of Lehe Science Popularization Academic Literature
New Medical Services
Second Consultation Rehabilitation and Wellness Elite Care
Oncology Clinical Research
Lung Cancer Stomach Cancer Hepatobiliary and Pancreatic Cancers Intestine Cancer Breast Cancer B-cell lymphoma Cervical Cancer Other Solid Tumors
Chronic Disease Research
Hypertension Diabetes Obesity Immune Diseases Degenerative Diseases Chronic Inflammation Others

Contact Us

Address: Room 1101 (Unit 101), 11th Floor, Building 1, No. 7 Courtyard, Kexueyuan Road, Life Science Park, Changping District, Beijing
Phone：010-8265 9866
Email：lehemedneo@hotmail.com

微信
抖音
哔哩哔哩
头条
Copyright©2022 Beijing Lehe New Medical Clinic Co., Ltd. All Rights Reserved ICP: 京ICP备2025148232号 京公网安备11011402054997号 Privacy Policy